Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
WEBINAR ENDED
Monday, May 11, 8:00 AM EDT · 4 hours

CAR T-Cell and Immune Effectors Workshop

May 11, 2020 at 08:00:00 AM · Eastern Time (US & Canada)
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Assistant Professor
I am a tumor immunologist with relevant expertise in T cell biology and cancer immunotherapy. I am deeply committed to rapidly advancing paradigm-shifting immunotherapy on behalf of patients with cancer, in part because of personal experience with family and friends who have struggled with the disease. I am an Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation at the City of Hope. We have recently developed two CAR T cell approaches for treating women with breast cancer brain metastasis and men with metastatic castration resistant prostate cancer - both have entered phase 1 clinical trials at City of Hope. My laboratory is focused on establishing clinically-relevant metastatic cancer models to evaluate combination/intrinsic gene editing strategies targeting immunosuppression and other immune pathways for improved durability and potency of adoptive cell therapy.
Webinar hosting presenter
Understanding Resistance to Develop Better CAR T Immunotherapies
Marco Ruella, MD, is Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies and Scientific Director of the Lymphoma Program at the Hospital of the University of Pennsylvania. His research focuses on the study of the mechanisms of relapse after chimeric antigen receptor T cell (CART) immunotherapies with the goal of rationally designing combined innovative immunotherapies for relapsing/refractory leukemia and lymphoma. He is the author of numerous peer-reviewed publications on targeted immunotherapies for hematological cancers and is an inventor in several patents on CAR T therapy. His work has been recognized through numerous awards including the inaugural SITC EMD-Serono Cancer Immunotherapy Clinical Fellowship (2014), the AACR-BMS Oncology Fellowship in Clinical Cancer Research (2015), the ASH Scholar Award (2016), a NIH K99-R00 award (2017), the “Paola Campese” Award Leukemia Research (2017), the Cancer Support Community Award (2018), and most recently the 2018 American Society of Hematology Joanne Levy, MD, Memorial Award for Outstanding Achievement. Dr. Ruella obtained his medical degree with high honors and completed his specialization in clinical hematology at the University of Torino, Italy. After completing his fellowship, he was an attending physician in the Hematology and Cell Therapy Division of the Mauriziano Hospital and an Instructor at the Biotechnology School at the University of Torino. From 2012, he was a postdoctoral fellow, and then an instructor at the University of Pennsylvania in the Center for Cellular Immunotherapies where he worked with Drs. June and Gill until appointment to his current position in 2018.
Webinar hosting presenter
Human CD83-targeted CAR T cells to prevent GVHD and eliminate AML
Associate Professor of Medicine
Division of Hematology, Oncology, and Transplantation
University of Minnesota
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts CAR T-Cell and Immune Effectors Workshop
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents
CAR_T-Cell_and_Immune_Effectors_Workshop_Syllabus.pdf
Preview Download Added by Alex Wendland at 5:45 PM - Thursday - May 7, 2020